Skip to main content

Advertisement

Log in

A plasmid encoding parts of the dengue virus E and NS1 proteins induces an immune response in a mouse model

  • Original Article
  • Published:
Archives of Virology Aims and scope Submit manuscript

Abstract

A DENV-2 plasmid named pEII*EIII/NS1*, containing sequences encoding portions of the envelope protein that are potentially involved in the induction of neutralizing antibodies and a portion of the NS1 sequence that is involved in protection, is reported in this work. The synthesized subunit protein was recognized by human sera from infected patients and had the predicted size. The immunogenicity of this construct was evaluated using a mouse model in a prime-boost vaccination approach. The priming was performed using the plasmid pEII*EIII/NS1*, followed by a boost with recombinant full-length GST–E and GST–NS1 fusion proteins. The mice showed specific antibody responses to the E and NS1 proteins, as detected by ELISA, compared to the response of animals vaccinated with the parental plasmid. Interestingly, some animals had neutralizing antibodies. These results show that EII*, EIII and NS1* sequences could be considered for the design of a recombinant subunit vaccine against dengue disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Aberle JH, Aberle SW, Allison SL, Stiasny K, Ecker M, Mandl CW, Berger R, Heinz FX (1999) A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms. J Immunol 163:6756–6761

    CAS  PubMed  Google Scholar 

  2. An LL, Whitton JL (1997) A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen. J Virol 71:2292–2302

    CAS  PubMed  Google Scholar 

  3. Bernardo L, Izquierdo A, Alvarez M, Rosario D, Prado I, Lopez C, Martinez R, Castro J, Santana E, Hermida L, Guillen G, Guzman MG (2008) Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates. Antiviral Res 80:194–199

    Article  CAS  PubMed  Google Scholar 

  4. Cahour A, Falgout B, Lai CJ (1992) Cleavage of the dengue virus polyprotein at the NS3/NS4A and NS4B/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A/NS4B may be processed by a cellular protease. J Virol 66:1535–1542

    CAS  PubMed  Google Scholar 

  5. Cedillo-Barron L, Foster-Cuevas M, Belsham GJ, Lefevre F, Parkhouse RM (2001) Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J Gen Virol 82:1713–1724

    CAS  PubMed  Google Scholar 

  6. Chang HH, Shyu HF, Wang YM, Sun DS, Shyu RH, Tang SS, Huang YS (2002) Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 (NS1): arginine-glycine-aspartic acid structural mimicry within the dengue viral NS1 antigen. J Infect Dis 186:743–751

    Article  CAS  PubMed  Google Scholar 

  7. Cheng HJ, Lin CF, Lei HY, Liu HS, Yeh TM, Luo YH, Lin YS (2009) Proteomic analysis of endothelial cell autoantigens recognized by anti-dengue virus nonstructural protein 1 antibodies. Exp Biol Med 234:63–73

    Article  CAS  Google Scholar 

  8. Chung KM, Nybakken GE, Thompson BS, Engle MJ, Marri A, Fremont DH, Diamond MS (2006) Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J Virol 80:1340–1351

    Article  CAS  PubMed  Google Scholar 

  9. Chung KM, Thompson BS, Fremont DH, Diamond MS (2007) Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cells. J Virol 81:9551–9555

    Article  CAS  PubMed  Google Scholar 

  10. Costa SM, Azevedo AS, Paes MV, Sarges FS, Freire, Alves AM (2007) DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice. Virology 358(20):413–423

    Article  CAS  PubMed  Google Scholar 

  11. Costa SM, Freire MS, Alves AM (2006) DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus. Vaccine 24:4562–4564

    Article  CAS  PubMed  Google Scholar 

  12. Costa SM, Paes MV, Barreto DF, Pinhao AT, Barth OM, Queiroz JL, Armoa GR, Freire MS, Alves AM (2006) Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence. Vaccine 24:195–205

    Article  CAS  PubMed  Google Scholar 

  13. Crill WD, Roehrig JT (2001) Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol 75:7769–7773

    Article  CAS  PubMed  Google Scholar 

  14. Delenda C, Staropoli I, Frenkiel MP, Cabanie L, Deubel V (1994) Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice. J Gen Virol 75:1569–1578

    Article  CAS  PubMed  Google Scholar 

  15. Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, Ennis FA, Rothman AL, Libraty DH (2004) Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis 189:990–1000

    Article  PubMed  Google Scholar 

  16. Etemad B, Batra G, Raut R, Dahiya S, Khanam S, Swaminathan S, Khanna N (2008) An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes. Am J Trop Med Hyg 79:353–363

    CAS  PubMed  Google Scholar 

  17. Goncalvez AP, Purcell RH, Lai CJ (2004) Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein. J Virol 78:12919–12928

    Article  CAS  PubMed  Google Scholar 

  18. Gorrochotegui-Escalante N, Gomez-Machorro C, Lozano-Fuentes S, Fernandez-Salas L, De Lourdes MM, Farfan-Ale JA, Garcia-Rejon J, Beaty BJ, Black WC (2002) Breeding structure of Aedes aegypti populations in Mexico varies by region. Am J Trop Med Hyg 66:213–222

    PubMed  Google Scholar 

  19. Gubler DJ (2002) Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10:100–103

    Article  CAS  PubMed  Google Scholar 

  20. Guzman MG, Kouri G (2002) Dengue: an update. Lancet Infect Dis 2:33–42

    Article  PubMed  Google Scholar 

  21. Guzman MG, Rodriguez R, Rodriguez R, Hermida L, Alvarez M, Lazo L, Mune M, Rosario D, Valdes K, Vazquez S, Martinez R, Serrano T, Paez J, Espinosa R, Pumariega T, Guillen G (2003) Induction of neutralizing antibodies and partial protection from viral challenge in Macaca fascicularis immunized with recombinant dengue 4 virus envelope glycoprotein expressed in Pichia pastoris. Am J Trop Med Hyg 69:129–134

    CAS  PubMed  Google Scholar 

  22. Hermida L, Bernardo L, Martin J, Alvarez M, Prado I, Lopez C, Sierra BL, Martinez R, Rodriguez R, Zulueta A, Perez AB, Lazo L, Rosario D, Guillen G, Guzman MG (2006) A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates. Vaccine 24:3165–3171

    Article  CAS  PubMed  Google Scholar 

  23. Hurtado-Diaz M, Riojas-Rodriguez H, Rothenberg SJ, Gomez-Dantes H, Cifuentes E (2007) Short communication: impact of climate variability on the incidence of dengue in Mexico. Trop Med Int Health 12:1327–1337

    Article  CAS  PubMed  Google Scholar 

  24. Katrak K, Mahon BP, Jones WC, Brautigam S, Mills KH (1992) Preparative separation of foreign antigens for highly efficient presentation to T cells in vitro. J Immunol Methods 156:247–254

    Article  CAS  PubMed  Google Scholar 

  25. Kelly EP, Greene JJ, King AD, Innis BL (2000) Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice. Vaccine 18:2549–2559

    Article  CAS  PubMed  Google Scholar 

  26. Khanam S, Khanna N, Swaminathan S (2006) Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors. Vaccine 24:6513–6525

    Article  CAS  PubMed  Google Scholar 

  27. Kochel T, Wu SJ, Raviprakash K, Hobart P, Hoffman S, Porter K, Hayes C (1997) Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice. Vaccine 15:547–552

    Article  CAS  PubMed  Google Scholar 

  28. Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, Jones CT, Mukhopadhyay S, Chipman PR, Strauss EG, Baker TS, Strauss JH (2002) Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108:717–725

    Article  CAS  PubMed  Google Scholar 

  29. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV (1992) Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30:545–551

    CAS  PubMed  Google Scholar 

  30. Lazaro-Olan L, Mellado-Sanchez G, Garcia-Cordero J, Escobar-Gutierrez A, Santos-Argumedo L, Gutierrez-Castaneda B, Cedillo-Barron L (2008) Analysis of antibody response in human dengue patients from the Mexican coast using recombinant antigens. Vector Borne Zoonotic Dis 8:69–80

    Article  CAS  PubMed  Google Scholar 

  31. Lazo L, Zulueta A, Hermida L, Blanco A, Sanchez J, Valdes I, Gil L, Lopez C, Romero Y, Guzman MG, Guillen G (2008) The Dengue-4 envelope domain III fused twice within the meningococcal P64k protein carrier induces partial protection in mice. Biotechnol Appl Biochem 52 (Pt):265–271

    Google Scholar 

  32. Limon-Flores AY, Perez-Tapia M, Estrada-Garcia I, Vaughan G, Escobar-Gutierrez A, Calderon-Amador J, Herrera-Rodriguez SE, Brizuela-Garcia A, Heras-Chavarria M, Flores-Langarica A, Cedillo-Barron L, Flores-Romo L (2005) Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells. Int J Exp Pathol 86:323–334

    Article  PubMed  Google Scholar 

  33. Mason PW, Zugel MU, Semproni AR, Fournier MJ, Mason TL (1990) The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherichia coli. J Gen Virol 71:2107–2114

    Article  CAS  PubMed  Google Scholar 

  34. Megret F, Hugnot JP, Falconar A, Gentry MK, Morens DM, Murray JM, Schlesinger JJ, Wright PJ, Young P, Van Regenmortel MH, Deubel V (1992) Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein. Virology 187:480–491

    Article  CAS  PubMed  Google Scholar 

  35. Mellado-Sanchez G, Garcia-Cordero J, Luria-Perez R, Lazaro-Olan L, Santos-Argumedo L, Gutierrez-Castaneda B, Estrada-Garcia I, Cedillo-Barron L (2005) DNA priming E and NS1 constructs—homologous proteins boosting immunization strategy to improve immune response against dengue in mice. Viral Immunol 18:709–721

    Article  CAS  PubMed  Google Scholar 

  36. Modis Y, Ogata S, Clements D, Harrison SC (2003) A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci USA 100:6986–6991

    Article  CAS  PubMed  Google Scholar 

  37. Modis Y, Ogata S, Clements D, Harrison SC (2005) Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol 79:1223–1231

    Article  CAS  PubMed  Google Scholar 

  38. Morens DM, Halstead SB, Repik PM, Putvatana R, Raybourne N (1985) Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol 22:250–254

    CAS  PubMed  Google Scholar 

  39. Oliphant T, Nybakken GE, Austin SK, Xu Q, Bramson J, Loeb M, Throsby M, Fremont DH, Pierson TC, Diamond MS (2007) Induction of epitope-specific neutralizing antibodies against West Nile virus. J Virol 81:11828–11839

    Article  CAS  PubMed  Google Scholar 

  40. Porter KR, Kochel TJ, Wu SJ, Raviprakash K, Phillips I, Hayes CG (1998) Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses. Arch Virol 143:997–1003

    Article  CAS  PubMed  Google Scholar 

  41. Putnak R, Cassidy K, Conforti N, Lee R, Sollazzo D, Truong T, Ing E, Dubois D, Sparkuhl J, Gastle W, Hoke C (1996) Immunogenic and protective response in mice immunized with a purified, inactivated, Dengue-2 virus vaccine prototype made in fetal rhesus lung cells. Am J Trop Med Hyg 55:504–510

    CAS  PubMed  Google Scholar 

  42. Putnak R, Feighny R, Burrous J, Cochran M, Hackett C, Smith G, Hoke C (1991) Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge. Am J Trop Med Hyg 45:159–167

    CAS  PubMed  Google Scholar 

  43. Putnak R, Fuller J, VanderZanden L, Innis BL, Vaughn DW (2003) Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes. Am J Trop Med Hyg 68:469–476

    CAS  PubMed  Google Scholar 

  44. Roehrig JT (2003) Antigenic structure of flavivirus proteins. Adv Virus Res 59:141–175

    Article  CAS  PubMed  Google Scholar 

  45. Roehrig JT, Bolin RA, Kelly RG (1998) Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 246:317–328

    Article  CAS  PubMed  Google Scholar 

  46. Schlesinger JJ, Brandriss MW, Walsh EE (1987) Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J Gen Virol 68:853–857

    Article  CAS  PubMed  Google Scholar 

  47. Simmons M, Porter KR, Hayes CG, Vaughn DW, Putnak R (2006) Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaques. J Virol 80:9577–9585

    Article  CAS  PubMed  Google Scholar 

  48. Srivastava AK, Putnak JR, Warren RL, Hoke CH Jr (1995) Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection. Vaccine 13:1251–1258

    Article  CAS  PubMed  Google Scholar 

  49. Sun W, Nisalak A, Gettayacamin M, Eckels KH, Putnak JR, Vaughn DW, Innis BL, Thomas SJ, Endy TP (2006) Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination. J Infect Dis 193:1658–1665

    Article  PubMed  Google Scholar 

  50. Timofeev AV, Butenko VM, Stephenson JR (2004) Genetic vaccination of mice with plasmids encoding the NS1 non-structural protein from tick-borne encephalitis virus and dengue 2 virus. Virus Genes 28:85–97

    Article  CAS  PubMed  Google Scholar 

  51. Vasquez-Ochoa M, Garcia-Cordero J, Gutierrez-Castaneda B, Santos-Argumedo L, Villegas-Sepulveda N, Cedillo-Barron L (2009) A clinical isolate of dengue virus and its proteins induce apoptosis in HMEC-1 cells: a possible implication in pathogenesis. Arch Virol 154:919–928

    Article  CAS  PubMed  Google Scholar 

  52. Wei HY, Jiang LF, Xue YH, Fang DY, Guo HY (2003) Secreted expression of dengue virus type 2 full-length envelope glycoprotein in Pichia pastoris. J Virol Methods 109:17–23

    Article  CAS  PubMed  Google Scholar 

  53. Wu SF, Liao CL, Lin YL, Yeh CT, Chen LK, Huang YF, Chou HY, Huang JL, Shaio MF, Sytwu HK (2003) Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice. Vaccine 21:3919–3929

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Héctor Romero-Ramírez for technical assistance and Dr. Milton Maciel, Jr. for critical reading of the manuscript. This work was supported in part by DENFRAME Consortium INCO 517711 and Consejo Nacional de Ciencia y Tecnología (CONACyT, México) Grant 49629-QLCB and 46168-M. Additionally, Gabriela Mellado-Sánchez and Jazmín García-Machorro received predoctoral fellowships from CONACyT.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leticia Cedillo-Barrón.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mellado-Sánchez, G., García-Machorro, J., Sandoval-Montes, C. et al. A plasmid encoding parts of the dengue virus E and NS1 proteins induces an immune response in a mouse model. Arch Virol 155, 847–856 (2010). https://doi.org/10.1007/s00705-010-0652-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00705-010-0652-x

Keywords

Navigation